Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Blood substitute" patented technology

A blood substitute (also called artificial blood or blood surrogate) is a substance used to mimic and fulfill some functions of biological blood. It aims to provide an alternative to blood transfusion, which is transferring blood or blood-based products from one person into another. Thus far, there are no well-accepted oxygen-carrying blood substitutes, which is the typical objective of a red blood cell transfusion; however, there are widely available non-blood volume expanders for cases where only volume restoration is required. These are helping doctors and surgeons avoid the risks of disease transmission and immune suppression, address the chronic blood donor shortage, and address the concerns of Jehovah's Witnesses and others who have religious objections to receiving transfused blood.

Perfusion fluid, methods of producing perfusion fluid, and its uses

PCT designated stageWO2026106498A1BiocideHalogenated hydrocarbon active ingredientsBiochemistryBlood substitute
The subject matter of the present invention is a perfusion fluid in the form of an oil-in-water PFC nanoemulsion, methods of producing this perfusion fluid, and its use in particular for organ perfusion and as a blood substitute preparation.
Owner:NANOSANGUIS SA

Acellular blood alternative for transfusion and organ perfusion

Compositions comprising Lumbricus terrestris erythrocruorin (LtEc) as an oxygen carrier for use in transfusion and organ perfusion are provided. In particular, methods of using acellular compositions comprising LtEc as a universal blood substitute for transfusion of patients are provided. The methods also include ex vivo perfusion of an organ or tissue with an oxygenated acellular perfusate comprising LtEc as an oxygen carrier. Additionally, methods are provided for using compositions comprising LtEc in treatment of acute ischemia and hyperbaric oxygen therapy.
Owner:RGT UNIV OF CALIFORNIA +1

Plasma substitute based on bletilla striata polysaccharide and preparation method thereof

The invention discloses blood substitute based on bletilla striata polysaccharide and a preparation method thereof, and relates to the technical field of blood substitute. The blood substitute is prepared from the following components in parts by weight: 3 to 5 parts of hydroxyethyl starch, 0.1 to 0.5 part of bletilla striata polysaccharide, 0.1 to 0.5 part of dendrobium officinale polysaccharide, 0.1 to 0.5 part of pullulan, 0.1 to 1 part of sodium chloride, 0.01 to 0.05 part of potassium chloride, 0.01 to 0.05 part of calcium chloride dihydrate, 0.01 to 0.05 part of magnesium chloride hexahydrate, 0.1 to 0.5 part of sodium lactate, 0.05 to 0.1 part of sodium acetate and 100 parts of water for injection. The plasma substitute provided by the invention has an excellent capacity expansion effect.
Owner:SICHUAN KANGYANGJIAN BIOTECHNOLOGY CO LTD

Culture medium and culture method of gamma delta T cells

The invention relates to the technical field of cell culture, in particular to a culture medium and a culture method of gamma delta T cells. In order to solve the problems of large batch-to-batch production difference, high biosafety risk, unstable supply chain and high cost caused by combined use of serum or blood substitution and multiple cytokines in the existing gamma delta T cell culture process, the serum-free culture medium containing GlutaMAX and IL-2 is obtained through screening, and the culture medium is applied to gamma delta T cell culture and has the advantages that the culture medium has a wide application prospect. The method can improve the process batch stability, can realize linear amplification, has higher purity and amplification efficiency, reduces the biological safety risk, can significantly reduce the supervision and production cost, and meets the GMP consistency requirement.
Owner:KEJING (CHENGDU) BIOTECHNOLOGY CO LTD

Blood transcriptome marker, kit, system, method and application for FDG-PET metabolic load evaluation

The invention discloses a blood transcriptome marker, a kit, a system, a method and application for FDG-PET metabolic load evaluation. The invention provides a blood substitution index of focus FDG-PET inflammation intensity, the substitution index comprises blood transcriptome markers GAS6 and GBP6 and a linear scoring model constructed based on the blood transcriptome markers GAS6 and GBP6, and the substitution index can be used for estimating or reflecting the metabolic load of a focus level in a layering manner and can be used for clinical diagnosis shunt and curative effect follow-up visit. According to the method, a small number of transcripts with the highest positive correlation degree with the focus SUVmax are identified in training data, a linear scoring model is constructed, the focus SUVmax / TGA is mapped and estimated according to the score, and / or whether an active focus exists or not is judged according to a threshold value. The scoring model is strongly and positively correlated with PET image indexes, and can be used as an alternative index of PET metabolic load to assist clinical lesion activity assessment and diagnosis shunting.
Owner:SHANGHAI PUBLIC HEALTH CLINICAL CENT

A spleen polypeptide extract, a preparation method and application thereof

The application relates to the technical field of biological extraction, and discloses a spleen polypeptide extract as well as a preparation method and application thereof. The preparation method takes fresh spleen tissue as raw material, and realizes preliminary separation of proteins, polypeptides and nucleic acids through an optimized isoelectric point grading process after pretreatment, homogenization, repeated freeze-thaw crushing, centrifugal separation and ultrafiltration grading, and finally obtains high-content products by adopting targeted chromatography purification technology. The spleen polypeptide extract and related products can be widely applied to the fields of biological medicines (such as immunomodulators and blood substitutes), food additives (such as protein fortifiers) and scientific reagent fields, the process is mild and has good repeatability, the comprehensive utilization of the spleen raw material is realized, the product added value is improved, and the application prospect of industrialization is good.
Owner:JILIN FENGSHENG PHARM CO LTD